Comparing Focalin XR vs Quillivant XR
| Focalin XR (dexmethylphenidate) | Quillivant XR (methylphenidate) |
|
|---|
| Focalin XR (dexmethylphenidate) | Quillivant XR (methylphenidate) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Focalin XR is an extended-release capsule that only needs to be taken once daily. It improves the symptoms of ADHD but carries with it a risk of dependence. Prescribed for ADHD. Focalin XR may also... View more |
Prescription only
Prescribed for ADHD. Quillivant XR may also be used for purposes not listed in this medication guide. |
Related suggestions ADHD (Attention Deficit Hyperactivity Disorder)
Popular comparisons
|
|||||||||||||||
| More about Focalin XR (dexmethylphenidate) | More about Quillivant XR (methylphenidate) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Focalin XR has an average rating of 6.8 out of 10 from a total of 117 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 24% reported a negative effect. |
Quillivant XR has an average rating of 5.7 out of 10 from a total of 23 ratings on Drugs.com. 43% of reviewers reported a positive effect, while 35% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Focalin XR side effects |
View all Quillivant XR side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Focalin XR prices |
View all Quillivant XR prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other dexmethylphenidate brands include: Focalin | Other methylphenidate brands include: Aptensio XR, Concerta, Cotempla XR-ODT, Daytrana, Jornay PM, Metadate CD, Methylin, Methylin ER, QuilliChew ER, Relexxii, Ritalin, Ritalin LA View more | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
3 hours |
4 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
High potential for abuse
Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 204 drugs are known to interact with Focalin XR:
|
A total of 207 drugs are known to interact with Quillivant XR:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
May 26, 2005 |
N/A |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
|||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.